Genomics & Molecular Engineering Core

基因组学

基本信息

  • 批准号:
    8011827
  • 负责人:
  • 金额:
    $ 19.93万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
  • 资助国家:
    美国
  • 起止时间:
  • 项目状态:
    未结题

项目摘要

The Genomic and Molecular Engineering (GME) Core of the DDRCC provides cutting-edge technologies for the analysis and manipulation of the genetic material. These new technologies empower DDRCC members to pinpoint and characterize genetic factors that influence the development and course of digestive diseases and to dissect gene functions In important pathways relevant to digestive diseases. The GME is a new Core, restructured from the former Molecular Biology and Biochemistry Core. The GME Core divided into two components. The Genotype Analysis component offers sen/ices relating to the genetic analysis of patient samples. The services of the Genotype Analysis component Include (1) customized single nucleotide polymorphism (SNP) genotyping based on the Sequenom Massanray genotyping platfonn, (2) standard SNP genotyping panels for high-Interest genes, (3) ultra-high throughput DNA sequence analysis for genotyping, (4) other genotype analysis methods (such as TaqMan), (5) DNA preparation, and (6) statistical genetics support. The Genetic Engineering component offers services relating to the manipulation of genes in cellular and organismal model systems. The services ofthe Genetic Engineering component include (1) somatic cell genetic manipulation of genes using homologous recombination to knock in or knock out mutations, (2) recombineering technologies to manipulate large DNA segments in bacterial artificial chromosomes, (3) the construction of gene expression constructs using lentiviral vectors for ectopic expression or silencing of genes, (4) support for realtime PCR, and (5) support for the Odyssey image analysis system. The GME Core supports members for genotype analysis and genetic engineering experiments by supporting labor cost, providing discounts for reagents, and training members in new technologies. The Administrative Directors of the GME Core, Drs. Nathan Ellis and David Boone, oversee the operations of the respective components. Directors are responsible for ensuring proper scientific direction and efficient use of services and facilities of the component resources. Usage of the GME Core rapidly increased from start-up because of substantial cost savings, relevance, and high quality of services and resources, and it is anticipated usage will grow substantially during the next cycle of this Grant. Each of the Components offers training of new and established investigators unfamiliar with the supported experimental approaches. The GME Core has helped to foster multidisciplinary collaborations and promote productive exchanges brought about by sharing of resources
DDRCC的基因组和分子工程(GME)核心为分析和操纵遗传物质提供了尖端技术。这些新技术使DDRCC成员能够查明和表征影响消化疾病发展和过程的遗传因素,并在与消化系统疾病有关的重要途径中剖析基因功能。 GME是一个新的核心,由以前的分子生物学和生物化学核心进行重组。 GME核心分为两个组件。基因型分析成分提供了与患者样品的遗传分析有关的SEN/ICE。 The services of the Genotype Analysis component Include (1) customized single nucleotide polymorphism (SNP) genotyping based on the Sequenom Massanray genotyping platfonn, (2) standard SNP genotyping panels for high-Interest genes, (3) ultra-high throughput DNA sequence analysis for genotyping, (4) other genotype analysis methods (such as TaqMan), (5) DNA preparation, (6)统计遗传学支持。 基因工程组件提供了与细胞和有机模型系统中基因操纵有关的服务。 The services ofthe Genetic Engineering component include (1) somatic cell genetic manipulation of genes using homologous recombination to knock in or knock out mutations, (2) recombineering technologies to manipulate large DNA segments in bacterial artificial chromosomes, (3) the construction of gene expression constructs using lentiviral vectors for ectopic expression or silencing of genes, (4) support for realtime PCR, and (5)支持奥德赛图像分析系统。 GME核心通过支持人工成本,为试剂提供折扣以及新技术的培训成员来支持成员进行基因型分析和基因工程实验。 GME核心的行政总监Drs。内森·埃利斯(Nathan Ellis)和大卫·布恩(David Boone)监督各个组件的运营。董事负责确保零件资源的服务和设施的适当科学方向和有效利用。 GME核心的使用量从启动迅速增加,这是因为节省了大量成本,相关性以及高质量的服务和资源,并且预计在该赠款的下一个周期中,用法将大大增长。每个组件都提供对不熟悉所支持的实验方法的新的和既定的研究人员的培训。 GME Core帮助促进了多学科合作,并通过共享资源来促进产生的富有成效的交流

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Nathan A. Ellis其他文献

The Xg blood group system: a review.
Xg 血型系统:回顾。
  • DOI:
    10.1016/s0887-7963(98)80001-1
  • 发表时间:
    1998
  • 期刊:
  • 影响因子:
    4.5
  • 作者:
    Patricia Tippett;Patricia Tippett;Nathan A. Ellis;Nathan A. Ellis
  • 通讯作者:
    Nathan A. Ellis
106 Implication of the 3′Utr Region of TGFβR1 With MSS HNPCC and Sporadic Colorectal Cancer
  • DOI:
    10.1016/s0016-5085(13)60086-4
  • 发表时间:
    2013-05-01
  • 期刊:
  • 影响因子:
  • 作者:
    Rosa M Xicola;Brian J. Doyle;Jamie Rawson;Pilar Garre;Anna Abulí;Sathyaraj Murugappan;Ji Yeon Lee;Xavier Bessa;Juan Clofent;Luis Bujanda;Francesc Balaguer;Sergi Castellvi-Bel;Cristina Alenda;Rodrigo Jover;Clara Ruiz-Ponte;Sapna Syngal;Montserrat Andreu;Angel Carracedo;Antoni Castells;Nathan A. Ellis
  • 通讯作者:
    Nathan A. Ellis
Report of the Second International Workshop on Y Chromosome Mapping 1995.
1995 年第二届 Y 染色体作图国际研讨会报告。
  • DOI:
  • 发表时间:
    1994
  • 期刊:
  • 影响因子:
    0
  • 作者:
    N. Affara;Charles M. Bishop;William Brown;H. Cooke;Phillip M. Davey;Nathan A. Ellis;J. Graves;Michael H. Jones;Michael J. Mitchell;G. A. Rappold;C. Tyler;P. Yen;Yun
  • 通讯作者:
    Yun
235 - Mutational and Epigenetic Spectrum of Colorectal Cancers in African Americans
  • DOI:
    10.1016/s0016-5085(17)30558-9
  • 发表时间:
    2017-04-01
  • 期刊:
  • 影响因子:
  • 作者:
    Rosa M. Xicola;Zarko Manojlovic;Gaius J. Augustus;Sonia S. Kupfer;John Carpten;Nathan A. Ellis;Xavier Llor
  • 通讯作者:
    Xavier Llor
Tu1100: HETEROZYGOUS MUTATIONS IN DNA REPAIR GENES CONFER GENETIC SUSCEPTIILITY TO COLORECTAL CANCER AMONG LYNCH-LIKE CASES
  • DOI:
    10.1016/s0016-5085(22)62088-2
  • 发表时间:
    2022-05-01
  • 期刊:
  • 影响因子:
  • 作者:
    Mar Giner-Calabuig;Seila V. De Leon;Gemma Vidal-Pedrola;Tara D. Fehlmann;Chinedu Ukaegbu;Joanna Gibson;Maria Dolores Picó;Cristina Alenda;Jose Reyes;Silvia P. Ortega;Catalina LLado;Paloma de la Torre Rubio;Antònia Obrador-Hevia;Adela Castillejo;Jose Luis Soto;Sergi Castellví-Bel;Sapna Syngal;Elena M. Stoffel;Nathan A. Ellis;Rodrigo Jover
  • 通讯作者:
    Rodrigo Jover

Nathan A. Ellis的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Nathan A. Ellis', 18)}}的其他基金

Epigenetic dysregulation in APC-negative colorectal cancer
APC 阴性结直肠癌的表观遗传失调
  • 批准号:
    10611424
  • 财政年份:
    2020
  • 资助金额:
    $ 19.93万
  • 项目类别:
Epigenetic dysregulation in APC-negative colorectal cancer
APC 阴性结直肠癌的表观遗传失调
  • 批准号:
    10400113
  • 财政年份:
    2020
  • 资助金额:
    $ 19.93万
  • 项目类别:
Epigenetic dysregulation in APC-negative colorectal cancer
APC 阴性结直肠癌的表观遗传失调
  • 批准号:
    10223247
  • 财政年份:
    2020
  • 资助金额:
    $ 19.93万
  • 项目类别:
Program 3: Cancer BiologyProgram (CBP)
计划 3:癌症生物学计划 (CBP)
  • 批准号:
    9315740
  • 财政年份:
    2017
  • 资助金额:
    $ 19.93万
  • 项目类别:
Genomic/Genetic and Proteome
基因组/遗传学和蛋白质组
  • 批准号:
    10871778
  • 财政年份:
    2016
  • 资助金额:
    $ 19.93万
  • 项目类别:
Regulation of Homologous Recombination in Human Cells
人类细胞同源重组的调控
  • 批准号:
    8449497
  • 财政年份:
    2011
  • 资助金额:
    $ 19.93万
  • 项目类别:
Regulation of Homologous Recombination in Human Cells
人类细胞同源重组的调控
  • 批准号:
    8041273
  • 财政年份:
    2011
  • 资助金额:
    $ 19.93万
  • 项目类别:
Regulation of Homologous Recombination in Human Cells
人类细胞同源重组的调控
  • 批准号:
    8906781
  • 财政年份:
    2011
  • 资助金额:
    $ 19.93万
  • 项目类别:
Regulation of Homologous Recombination in Human Cells
人类细胞同源重组的调控
  • 批准号:
    8268383
  • 财政年份:
    2011
  • 资助金额:
    $ 19.93万
  • 项目类别:
Genetic risk factors in African American colorectal cancer patients
非裔美国结直肠癌患者的遗传危险因素
  • 批准号:
    8705888
  • 财政年份:
    2010
  • 资助金额:
    $ 19.93万
  • 项目类别:

相似海外基金

Core A: Administrative Core
核心A:行政核心
  • 批准号:
    10654530
  • 财政年份:
    2022
  • 资助金额:
    $ 19.93万
  • 项目类别:
Core A: Administrative Core
核心A:行政核心
  • 批准号:
    10333055
  • 财政年份:
    2022
  • 资助金额:
    $ 19.93万
  • 项目类别:
Do Tumor-Immune Interactions Prime Systemic Tolerance of Triple-Negative Breast Cancer Brain Metastases?
肿瘤免疫相互作用是否会导致三阴性乳腺癌脑转移的全身耐受性?
  • 批准号:
    10411906
  • 财政年份:
    2021
  • 资助金额:
    $ 19.93万
  • 项目类别:
Do Tumor-Immune Interactions Prime Systemic Tolerance of Triple-Negative Breast Cancer Brain Metastases?
肿瘤免疫相互作用是否会导致三阴性乳腺癌脑转移的全身耐受性?
  • 批准号:
    10115537
  • 财政年份:
    2021
  • 资助金额:
    $ 19.93万
  • 项目类别:
Leveraging human evolutionary history to improve our understanding of complex disease architecture
利用人类进化史来提高我们对复杂疾病结构的理解
  • 批准号:
    10456685
  • 财政年份:
    2021
  • 资助金额:
    $ 19.93万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了